Market Tracker

09/29 5:16pm ET

Amicus Therapeutics Inc (NASDAQ:FOLD)

7.07
Delayed Data
As of 4:00pm ET
 -0.55 / -7.22%
Today’s Change
4.98
Today|||52-Week Range
14.48
-27.11%
Year-to-Date
3 Biotechs With Potential Big-Time Upside
Sep 26 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close7.62
Today’s open7.69
Day’s range7.07 - 7.69
Volume3,031,858
Average volume (3 months)2,297,714
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-29.03%
Earnings growth (this year)-12.10%
Earnings growth (next 5 years)+38.44%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.74

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...-0.35-0.50%
RGENRepligen Corp-1.87-5.95%
MGNXMacroGenics Inc-2.94-9.08%
LCILannett Company Inc-1.27-4.53%
Data as of 4:01pm ET, 09/29/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$0.00
Annual profit (last year)-$132.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts